Philipp Koehler

Philipp Koehler publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Philipp Koehler sits on this spectrum.

Philipp Koehler D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Philipp Koehler sits on this spectrum.

Best Publications

• Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

  Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  894
  Citations

• COVID-19 associated pulmonary aspergillosis.

  Philipp Koehler;Oliver A. Cornely;Bernd W. Böttiger;Fabian Dusse

  549
  Citations

• COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment

  Amir Arastehfar;Agostinho Carvalho;Frank L. van de Veerdonk;Jeffrey D. Jenks

  408
  Citations

• Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

  Martin Hoenigl;Jon Salmanton-García;Thomas J. Walsh;Thomas J. Walsh;Marcio Nucci

  391
  Citations

• Low-Avidity CD4 + T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.

  Petra Bacher;Elisa Rosati;Daniela Esser;Gabriela Rios Martini

  311
  Citations

• COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

  Livio Pagano;Livio Pagano;Jon Salmanton-García;Francesco Marchesi;Alessandro Busca

  310
  Citations

• Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis.

  Philipp Koehler;Melanie Stecher;Oliver A Cornely;Daniela Koehler

  296
  Citations

• COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.

  Jon Salmanton-García;Rosanne Sprute;Jannik Stemler;Michele Bartoletti

  252
  Citations

• Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.

  Juergen Prattes;Joost Wauters;Daniele Roberto Giacobbe;Jon Salmanton-García

  214
  Citations

• Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

  Unknown

  198
  Citations

• Diagnosing COVID-19-associated pulmonary aspergillosis.

  Paul E. Verweij;Jean Pierre Gangneux;Matteo Bassetti;Roger J.M. Brüggemann

  186
  Citations

• Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

  Unknown

  153
  Citations

• Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.

  Paul E. Verweij;Paul E. Verweij;Roger J.M. Brüggemann;Elie Azoulay;Matteo Bassetti

  150
  Citations

• Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.

  Unknown

  143
  Citations

• Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.

  Sebastian J Theobald;Alexander Simonis;Theodoros Georgomanolis;Christoph Kreer

  143
  Citations

• Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.

  Unknown

  142
  Citations

• Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

  Unknown

  130
  Citations

• Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy.

  Jeffrey D. Jenks;Sharon L. Reed;Danila Seidel;Philipp Koehler

  102
  Citations

• European candidaemia is characterised by notable differential epidemiology and susceptibility pattern; Results from the ECMM Candida III study.

  Unknown

  99
  Citations

• Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

  Philipp Koehler;Axel Hamprecht;Oliver Bader;Isabelle Bekeredjian-Ding

  96
  Citations